Supply order for Covishield vaccine was placed after drug regulator approved it: Govt
Union Minister of State for Health Ashwini Choubey was responding to a question on whether the government has finalised a pricing and supply agreement with the Serum Institute of India Limited for COVID-19 vaccines. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 2, 2021 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches generic epilepsy drug in US market
"We are pleased that this product has been designated as a Competitive Generic Therapy (CGT) by the FDA," Dr Reddy's Laboratories North America Generics CEO Marc Kikuchi said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 2, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech hails Rs 35,000 crore budget allocation for COVID-19 vaccination
Welcoming the proposal for Rs 35,000 crore outlay for COVID-19 vaccines, city-based Bharat Biotech Chairman and Managing Director Krishna Ella said "Its a great step ahead, and far-reaching budget announcement., providing Rs 35,000 crore for COVID-19 vaccination in 2021-22." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 1, 2021 Category: Pharmaceuticals Source Type: news

Granules arm gets American health regulator's nod for Potassium Chloride Oral Solution
In a BSE filing, Granules said the US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI), a wholly-owned foreign subsidiary of Granules India Ltd, for Potassium Chloride Oral Solution USP. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 1, 2021 Category: Pharmaceuticals Source Type: news

Budget 2021: Big leg-up for healthcare, major move on vehicle scrapping to tackle pollution
The areas of focus will be preventive and curative healthcare as well as well being, she said. The allocation is likely to be around Rs 2,23,846 crore, a 137% percentage rise from the previous budget. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 1, 2021 Category: Pharmaceuticals Source Type: news

FM lays foundation of Atmanirbhar Bharat; announces Rs 35,000 crore for vaccines development
‚Äč‚ÄčThis is the most important pillar of the vision for Atmanirbhar and Swachh Bharat, said Finance Minister Sitharaman. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 1, 2021 Category: Pharmaceuticals Source Type: news

89 lakh kids below 5 years given polio drops across India on 'Polio Ravivar': Health ministry
"The booth activity will be followed by house-to-house surveillance (mop-up rounds) over the next two to five days to identify and vaccinate children who missed getting vaccinated at the booths," the ministry said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 31, 2021 Category: Pharmaceuticals Source Type: news

Serum Institute of India plans to launch Covovax by June: Adar Poonawalla
SII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We have applied for starting trials in India. Hope to launch Covocax by June 2021," Poonawalla said in a tweet. The new vaccine shall be launched under the brand name of Covovax, which SII is manufacturing in partnership with Novovax. The Pune-based global vaccine giant has sought permission from the DCGI to start domestic trials of the new product. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 30, 2021 Category: Pharmaceuticals Source Type: news

Serum Institute applies for trials of another Covid vaccine- Covovax
The country launched its COVID-19 vaccination drive from January 16 in what Prime Minister Narendra Modi has called the world's largest inoculation programme with priority to be given to nearly three crore healthcare and frontline workers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 30, 2021 Category: Pharmaceuticals Source Type: news

Supply of COVID-19 vaccines may meet, even outstrip demand in India by Q3: AstraZeneca chief
"I am very hopeful given our enterprise, given the number of vaccines India is developing and the capacity available, hopefully in my own personal read, by quarter 3, we may actually have a situation where supply will meet up the demand or even outstrip," AstraZeneca Pharma India Country President and MD Gagan Singh said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 29, 2021 Category: Pharmaceuticals Source Type: news

Time for India to become pharmacy of the world: Economic Survey
The Economic Survey calls for restructuring the current regulatory mechanism, upgrading and building capacities at various National Institute of Pharmaceutical Education and Research (NIPERs). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 29, 2021 Category: Pharmaceuticals Source Type: news

Dr Reddy's to seek approval for Sputnik V jab by March
In September last, Dr. Reddy's partnered with Russian Direct Investment Fund (RDIF) to conduct the clinical trials of the Sputnik V vaccine and for its distribution rights in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 29, 2021 Category: Pharmaceuticals Source Type: news

Accord 'strategic sector' tag to pharma industry: Parliamentary panel
The Committee on Public Undertakings said it was of the strong opinion that pharma sector plays a very important role to keep the nation healthy and strong. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 29, 2021 Category: Pharmaceuticals Source Type: news

India's Serum Institute seeks approval to conduct local trial for Novavax COVID-19 vaccine
Novavax's UK trial, which enrolled 15,000 people aged 18 to 84, is expected to be used to apply for use in Britain, the European Union and other countries. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 29, 2021 Category: Pharmaceuticals Source Type: news

USFDA grants orphan drug designation to Zydus Cadila's Saroglitazar Mg
Zydus Cadila, which is a part of Cadila Group, said orphan drug designation provides eligibility for certain development incentives, including tax credits for qualified clinical testing, prescription drug user fee exemptions and seven-year marketing exclusivity upon USFDA approval. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 28, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech, SII approach DCGI for using COVID vaccine on those using blood thinners: ICMR DG
Oxford COVID-19 vaccine 'Covishield' manufactured by the Serum Institute of India (SII) and indigenously developed 'Covaxin' of Bharat Biotech have been approved by the Drugs Controller General of India (DCGI) for restricted emergency use in the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 28, 2021 Category: Pharmaceuticals Source Type: news

Covaxin is successful in tackling UK strain: ICMR DG Balram Bhargava
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 28, 2021 Category: Pharmaceuticals Source Type: news

Five or six doses? Controversy over Pfizer vaccine vials
Pfizer has revised higher its production target for this year from 1.3 billion doses to 2 billion. While part of that reflects plans to further increase output, it also reflects the effect of the label change on vials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2021 Category: Pharmaceuticals Source Type: news

India's Dr.Reddy's ends study of COVID-19 drug Avigan in Kuwait
Data from the Kuwait trial, conducted in partnership with United Arab Emirates-based medical alliance Global Response Aid FZCO (GRA), showed that the difference in time taken by Avigan and placebo to resolve a sustained absence of oxygen in the tissues was not significant enough to continue the trial. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2021 Category: Pharmaceuticals Source Type: news

India's coronavirus vaccine, COVAXIN, likely effective against new British variant: Study
A study conducted by Indian Council of Medical Research (ICMR) on Covaxin showed a comparable neutralization activity of the vaccinated individuals against UK-variant strain. Covaxin, an indigenously developed and manufactured by Hyderabad based Bharat Biotech in collaboration with ICMR and National Institute of Virology (NIV). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2021 Category: Pharmaceuticals Source Type: news

68% of South African Indians willing to take COVID-19 vaccine: Study
Last week, South Africa's health regulatory body granted approval to the world's largest drug manufacturer Serum Institute of India (SII) to supply COVID-19 vaccine to the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2021 Category: Pharmaceuticals Source Type: news

Nepal kicks off inoculations against coronavirus with India's AstraZeneca vaccine
Tens of thousands of Nepal's frontline health workers are set to receive India's AstraZeneca vaccine, caretaker Prime Minister K.P. Sharma Oli said as the drive began. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2021 Category: Pharmaceuticals Source Type: news

Unichem Labs gets USFDA nod to market generic capsules
The company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2021 Category: Pharmaceuticals Source Type: news

Moderna says its vaccine works against variants, developing booster shot
Pfizer, which makes a similar COVID-19 vaccine, has previously reported that its shot also appears effective against the strain from Britain. But other research has raised questions about the variant from South Africa. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 26, 2021 Category: Pharmaceuticals Source Type: news

Saudi Arabia to get three million AstraZeneca shots in a week from India's Serum Institute
SII, the world's biggest vaccine manufacturer, has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance to make up to a billion doses for poorer countries. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 26, 2021 Category: Pharmaceuticals Source Type: news

Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in Mexico
In June 2020, Zydus Cadila had received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate Desidustat in the management of COVID-19. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 25, 2021 Category: Pharmaceuticals Source Type: news

Vietnam offers significant opportunities for Indian generic drugmakers: Fitch Solutions
India is Vietnam's third largest supplier of pharmaceutical products, with an export turnover of USD 198 million in the first nine months of 2020. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 25, 2021 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA nod to market generic Sevelamer Carbonate tablets
The product is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis, Lupin said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 25, 2021 Category: Pharmaceuticals Source Type: news

Strides Pharma gets USFDA nod for generic drug
Bengaluru-based Strides Pharma has 127 cumulative abbreviated new drug applications (ANDA) filings with USFDA of which 96 have been approved and 31 are pending approval. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 25, 2021 Category: Pharmaceuticals Source Type: news

Tata in talks to launch Moderna vaccine in India
Tata Medical& Diagnostics, a newly formed subsidiary of Tata Sons, is said to have started initial discussions with US company Moderna for a partnership to launch its Covid-19 vaccine in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 25, 2021 Category: Pharmaceuticals Source Type: news

Inside the world's biggest vaccine factory, Serum Institute of India
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 24, 2021 Category: Pharmaceuticals Source Type: news

How India is scaling up the vaccination process
The government plans to launch a drive to address concerns and scale up daily numbers. India aims to vaccinate 300 million healthcare and frontline workers in this initial phase. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 24, 2021 Category: Pharmaceuticals Source Type: news

India to give homegrown vaccine in seven more states this week
The government this month gave emergency-use approval to the vaccine, developed by Bharat Biotech International Ltd and state-run Indian Council of Medical Research, and another licensed from Oxford University and AstraZeneca PLC that is being manufactured by the Serum Institute of India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 24, 2021 Category: Pharmaceuticals Source Type: news

Barbados PM requests PM Modi for access to Oxford-AstraZeneca vaccine being manufactured in India
In a letter addressed to Prime Minister Narendra Modi, Barbados PM has asked access to 200,000 doses of the Oxford-AstraZeneca vaccine being manufactured in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 23, 2021 Category: Pharmaceuticals Source Type: news

South Africa's regulatory body approves Serum Institute of India's coronavirus vaccine
Health Minister Zweli Mkhize announced on Friday that the South African Health Products Regulatory Authority (SAHPRA) has granted approval to the SII, which is producing the vaccine in collaboration with the University of Oxford and AstraZeneca, to supply the drug to the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 23, 2021 Category: Pharmaceuticals Source Type: news

Inside the world's biggest vaccine factory, India's Serum Institute
The firm, founded in 1966 in the western city of Pune, is producing millions of doses of the Covishield vaccine, developed by AstraZeneca and Oxford University, for India and much of the developing world. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 23, 2021 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for thyroid drug
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Liothyronine Sodium tablets USP, 5 mcg, 25 mcg, and 50 mcg, Cadila Healthcare said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 23, 2021 Category: Pharmaceuticals Source Type: news

Understanding reluctance of citizens with COVID-19 vaccine shows surprising results
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 22, 2021 Category: Pharmaceuticals Source Type: news

Sputnik vaccine to cost less than $10 in India, nod likely soon
Russian Development Investment Fund (RDIF), which is backing the Sputnik V vaccine, on Thursday said it expects to register the vaccine in India soon and will price it at less than $10 per dose. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 22, 2021 Category: Pharmaceuticals Source Type: news

Biocon reports 17% drop in net profit, Christiane Hamacher steps down as MD of Biocon Biologics
“2020 has been one of the most challenging years for the world with an unprecedented pandemic impact on the global economy. We continue to face headwinds across operational, regulatory and commercial functions which have been deterrents to our planned market expansion. However, we expect normaliza tion by next fiscal,” said Kiran Mazumdar-Shaw, executive chairperson, Biocon. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 22, 2021 Category: Pharmaceuticals Source Type: news

Rhizen receives USFDA orphan drug designation for cancer drug
The US Food and Drug Administration (USFDA) has granted orphan drug designation for Tenalisib (RP6530) for the treatment of patients with peripheral T-cell lymphoma (PTCL), Alembic Pharmaceuticals said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 22, 2021 Category: Pharmaceuticals Source Type: news

Vaccines for free or at open market prices? India's got a big dilemma ahead of budget
The country will need $1.4 billion to inoculate over 300 million people in the first phase of the vaccine rollout. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 22, 2021 Category: Pharmaceuticals Source Type: news

India's Bharat Biotech seeks emergency use approval for vaccine in Philippines
Bharat Biotech, which has developed COVAXIN with the Indian Council of Medical Research, is the fourth vaccine maker to apply for emergency use in the Philippines. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 21, 2021 Category: Pharmaceuticals Source Type: news

India's Bharat Biotech seeks Bangladesh trial for COVID vaccine
If allowed to go ahead, this would be the first trial of any coronavirus vaccine in Bangladesh and could give the densely-populated country of more than 160 million faster access to the shot for mass use. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 21, 2021 Category: Pharmaceuticals Source Type: news

Fire breaks out at Terminal 1 gate of Pune Serum Institute of India
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 21, 2021 Category: Pharmaceuticals Source Type: news

Vaccine hesitancy 39 per cent in Delhi-NCR: Survey
The findings of the fourth round of the Delhi-NCR Coronavirus Telephone Survey (DCVTS-4) conducted by the economic think-tank NCAER showed that about 20 per cent respondents were certain about not taking the vaccine. Of this, 22.4 per cent were from rural areas and 17.5 per cent from urban locations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 21, 2021 Category: Pharmaceuticals Source Type: news

India to begin commercial vaccine exports with shipments to Brazil, Morocco
The shots developed by UK-based drugmaker AstraZeneca and Oxford University are being manufactured at the Serum Institute of India, the world's biggest producer of vaccines, which has received orders from countries across the world. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 21, 2021 Category: Pharmaceuticals Source Type: news

COVID vaccine: Nearly 10 lakh beneficiaries vaccinated so far, says Health Ministry
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 21, 2021 Category: Pharmaceuticals Source Type: news

Vaccination Trends: Two southern states top India, youth yet to warm up
Karnataka and Andhra Pradesh have topped the charts in India's Covid-19 vaccination drive with each inoculating more than 80,000 healthcare workers since Saturday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 21, 2021 Category: Pharmaceuticals Source Type: news

Indian vaccines gifted to Bangladesh & Nepal to reach on Thursday
The vaccine delivery is termed as a “gift from the people of India to the people of Bangladesh”. It is also the fulfilment of the assurance given by Prime Minister Modi to Bangladesh Prime Minister Sheikh Hasina during the recent December 17, 2020 Virtual Summit, that India would facilitate supply of vaccines as and when ready. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 20, 2021 Category: Pharmaceuticals Source Type: news